1. Targets and Indicators Monitoring and Evaluation
Alasdair Reid

2. Outline
Why M&E?
Simple guide to M&E of collaborative TB/HIV programme activities
Developing Indicators and targets

3. WHY M&E? Ensuring quality Programme management
Promote a learning culture
Accountability
Attract resources

4. Guide to M&E Strengthen M&E systems at all levels Uniformity
Avoid duplication

5. M&E for TB/HIV Develop guidelines for M&E
Identify minimum core indicators and targets
Develop reporting tools for M&E at all levels
Recommend the frequency of reporting
Identify minimum resource requirements
Consider additional indicators for special circumstances or for evaluation of new interventions

6. Who for?
National TB, HIV and TB/HIV programme managers and coordinators
Service deliverers
Funders

7. Guide to M&E Outline draft
Introduction and background
Brief overview of M&E
Overview of collaborative TB/HIV programme activities
Framework for TB/HIV M&E
Operationalisation
Indicators & targets

8. Indicators and targets
Aim – Objectives – Activities
– Indicators – Targets

9. Indicators
AIM: To decrease the burden of TB in populations where HIV may fuel the TB epidemic:
interventions against TB (DOTS strategy, ICF and TB preventive treatment)
interventions against HIV (and therefore indirectly against TB), e.g. condoms, STI treatment, HAART

10. Objectives Project proposals
Guidelines for implementing collaborative TB and HIV programme activities

11. Activity areas Background/Baseline data
Strengthening health services/systems
HIV counselling and testing
Strengthening DOTS and ICF
Strengthening HIV prevention
Care and support for people with TB/HIV
Costs and cost-effectiveness
Stigma?

12. Indicator fields Indicator Series and Title Brief Description
Core/Desirable/Optional
Definition: numerator and denominator, what it measures
Strengths and limitations
Data source
Resource requirements

13. Indicator fields
Level
Periodicity
Indicator source
Targets

14. Indicators Simple Minimal resources Easy to collect
Useful to health service providers
Rapid feedback
Avoid cohort analysis unless necessary

15. Indicators